INVO Fertility Stock-Based Compensation Growth & History (IVF)

INVO Fertility's stock-based compensation was $162,920 for fiscal 2025.

View full INVO Fertility company overview

INVO Fertility annual stock-based compensation history

INVO Fertility annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$162,920−$1.4M−89.75%
20242024-12-31$1.6M$196,151+14.08%
20232023-12-31$1.4M−$222,906−13.79%
20222022-12-31$1.6M$72,489+4.70%
20212021-12-31$1.5M$402,923+35.31%
20202020-12-31$1.1M$1.1M+1534.96%
20192019-12-31$69,787$69,787
20182018-12-31$0

INVO Fertility stock-based compensation trends

Over the last five fiscal years, INVO Fertility's stock-based compensation decreased from $1.1M to $162,920, a change of −$978,069. The latest reported quarter, Q2 2026, shows $189,492.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review INVO Fertility source filings ↗

Community posts

It’s quiet here.

No posts about IVF yet. Start the conversation.

Write the first post